精神分裂症女性妊娠期抗精神病药持续使用与产后复发风险:全国登记研究
该回顾性队列研究基于韩国国民健康信息数据库,纳入2007年至2018年分娩活婴的精神分裂症女性3026例(中位年龄34岁,四分位距31-37),按分娩前12个月抗精神病药使用模式分为未使用、中断和持续使用三组,产后6个月因精神病入院的风险在持续使用组低于中断组(相对风险比0.56,95%CI 0.36-0.87)。作者认为妊娠期持续使用抗精神病药与产后复发风险降低相关,并建议在风险-获益评估后推荐妊娠期继续使用抗精神病药。
要点
- 产后6个月因精神病入院风险:持续使用组IRR=1.31(95%CI 0.89-1.72),中断组IRR=2.34(95%CI 1.87-2.91)。
- 持续使用组产后6个月因精神病入院风险为中断组的0.56倍(相对风险比95%CI 0.36-0.87)。
- 中断组中,停药时机与产后6个月因精神病入院IRR无显著变化(趋势P=0.946)。
核心结论
- 妊娠期持续使用抗精神病药与精神分裂症女性产后复发风险降低相关。
- 作者认为,在风险-获益评估后推荐妊娠期继续使用抗精神病药。
研究设计与样本
- 回顾性队列研究,数据来自韩国国民健康信息数据库,纳入2007年至2018年分娩活婴的精神分裂症女性。
- 共纳入3026例女性,中位年龄34岁,四分位距31-37岁。
- 按分娩前12个月抗精神病药使用模式分为未使用、中断和持续使用三组。
- 复发定义为因精神病入院(ICD-10,F20-29)。
- 采用条件泊松回归估计产后6个月因精神病入院的发病率比,参考期为分娩前2年至1年。
主要发现
- 产后6个月因精神病入院风险:持续使用组IRR=1.31(95%CI 0.89-1.72),中断组IRR=2.34(95%CI 1.87-2.91)。
- 持续使用组产后6个月因精神病入院风险为中断组的0.56倍(相对风险比95%CI 0.36-0.87)。
- 中断组中,停药时机与产后6个月因精神病入院IRR无显著变化(趋势P=0.946)。
临床怎么用
- 作者认为,在风险-获益评估后推荐妊娠期继续使用抗精神病药。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with schizophrenia frequently discontinue antipsychotic medications during pregnancy. However, evidence on the risk of postpartum relapse associated with antipsychotic use during pregnancy is lacking. AIMS: To investigate the within-individual association between antipsychotic continuation during pregnancy and postpartum relapse in women with schizophrenia. METHOD: This retrospective cohort study used data of women with schizophrenia who gave live birth between 2007 and 2018 identified from the National Health Information Database of South Korea. Women were classified according to antipsychotic use patterns during the 12 months before delivery as non-users, discontinuers and continuers. Relapse was defined as admission for psychosis (ICD-10, F20-29). The incidence rate ratio (IRR) for admission for psychosis in the 6-month postpartum period was estimated using conditional Poisson regression, with the reference period set between 2 and 1 years before delivery. Additionally, we calculated the relative risk ratios (RRRs) for the IRRs of different antipsychotic use patterns. RESULTS: Among the 3026 women included in the analysis (median age 34 years, interquartile range 31-37), the within-individual risk of admission for psychosis in the 6-month postpartum period was 0.56 times (RRR, 95% CI 0.36-0.87) lower in continuers (IRR = 1.31, 95% CI 0.89-1.72) than in discontinuers (IRR = 2.34, 95% CI 1.87-2.91). Among discontinuers, the IRRs of admission for psychosis in the 6-month postpartum period did not change significantly with the timing of discontinuation (trend P = 0.946). CONCLUSIONS: Antipsychotic continuation during pregnancy was associated with a reduced risk of postpartum relapse in women with schizophrenia. Continuing antipsychotics during pregnancy would be recommended after a risk-benefit assessment.
引用
- Kang S, Yang JS, Yun BH, et al. Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study. Br J Psychiatry. 2025. PMID: 39789797. doi:10.1192/bjp.2024.247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。